In summary, the exciting findings gathered in the last decade clearly highlight an important role for chemerin in the regulation of energy balance and makes it a promising candidate for urgently needed pharmacological treatment strategies for obesity. This evidence concerns the gene RARRES2 and obesity due to melanocortin 4 receptor deficiency.